ORELOX JUNIOR


Suspension
scheduling status
S4
registration number
27/20.1.1/0564
What ORELOX JUNIOR contains
Each 5 mL of suspension contains 52,18 mg of cefpodoxime proxetil equivalent to 40 mg of cefpodoxime.
other ingredients
Anhydrous colloidal silica Aspartame Banana flavour Carboxymethylcellulose calcium Carboxymethylcellulose sodium Citric acid monohydrate Hydroxypropylcellulose Iron oxide yellow (E172) Lactose monohydrate Monosodium glutamate Potassium sorbate Sodium chloride Sorbitan trioleate Sucrose Talc.
Therapeutic classification
J01DD13.
© 2026 SAHPRA. ALL RIGHTS RESERVED